This announcement is a separate document:
富士製薬工業：ウステキヌマブ（遺伝子組換え）製剤のバイオ後続品（バイオシミラー）の 製造販売承認取得のお知らせ
Fuji Pharma: Notice of obtaining approval for manufacture and sale of biosuccessors (biosimilars) of ustekinumab (genetically modified) preparations
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.